145 related articles for article (PubMed ID: 1903766)
1. Failure of a tumour to prime CTL specific for some of the minor H antigens it expresses but not others.
Johnson LL
Immunology; 1991 Apr; 72(4):532-6. PubMed ID: 1903766
[TBL] [Abstract][Full Text] [Related]
2. Tumour-induced immunity to H-Y-disparate skin grafts without concomitant priming of CTL.
Johnson LL; Hines DL
Immunology; 1990 Jan; 69(1):85-90. PubMed ID: 2312158
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic T lymphocyte response to minor H-42a alloantigen in H-42b mice: clonal inactivation of the precursor cytotoxic T lymphocytes by veto-like spleen cells that express the H-42a antigen.
Ishikawa H; Hino T; Kato H; Suzuki H; Saito K
J Immunol; 1986 Oct; 137(7):2080-8. PubMed ID: 3489752
[TBL] [Abstract][Full Text] [Related]
4. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
[TBL] [Abstract][Full Text] [Related]
5. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes.
Keene JA; Forman J
J Exp Med; 1982 Mar; 155(3):768-82. PubMed ID: 6801178
[TBL] [Abstract][Full Text] [Related]
6. Nonresponsiveness to the male antigen H-Y in H-2 I-A-mutant B6.C-H-2bm12 is not caused by defective antigen presentation.
de Waal LP; de Hoop J; Stukart MJ; Gleichmann H; Melvold RW; Melief CJ
J Immunol; 1983 Feb; 130(2):655-60. PubMed ID: 6401303
[TBL] [Abstract][Full Text] [Related]
7. Helper effects required during in vivo priming for a cytolytic response to the H-Y antigen in nonresponder mice.
Juretić A; Malenica B; Juretić E; Klein J; Nagy ZA
J Immunol; 1985 Mar; 134(3):1408-14. PubMed ID: 2578505
[TBL] [Abstract][Full Text] [Related]
8. Antigen competition in cytotoxic T cell response to minor histocompatibility antigens.
Lai PK
Transplantation; 1985 Jun; 39(6):638-43. PubMed ID: 3873732
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T lymphocyte nonresponsiveness to the male antigen H-Y in the H-2Db mutants bm13 and bm14. Complementation of the response in F1 crosses with the I-Ab mutant bm12 nonresponder and failure of B6 or Db mutant mice tolerant of each other to respond to allogeneic male cells.
De Waal LP; Melvold RW; Melief CJ
J Exp Med; 1983 Nov; 158(5):1537-46. PubMed ID: 6415206
[TBL] [Abstract][Full Text] [Related]
10. In vivo priming of mouse CTL precursors directed to product of a newly defined minor H-42 locus is under a novel control of class II MHC gene.
Ishikawa H; Suzuki H; Hino T; Kubota E; Saito K
J Immunol; 1985 Dec; 135(6):3681-5. PubMed ID: 3934264
[TBL] [Abstract][Full Text] [Related]
11. Two roles for CD4 cells in the control of the generation of cytotoxic T lymphocytes.
Cassell D; Forman J
J Immunol; 1991 Jan; 146(1):3-10. PubMed ID: 1670605
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
Muraoka S
Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumors.
Schirmbeck R; Böhm W; Reimann J
J Immunol; 1996 Oct; 157(8):3550-8. PubMed ID: 8871655
[TBL] [Abstract][Full Text] [Related]
14. Reduced diversity of CTLs specific for multiple minor histocompatibility antigens relative to allograft rejection in vivo.
Nevala WK; Paul C; Wettstein PJ
J Immunol; 1997 Feb; 158(3):1102-7. PubMed ID: 9013948
[TBL] [Abstract][Full Text] [Related]
15. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
16. Alloreactive T cells that do not require TCR and CD8 coengagement are present in naive mice and contribute to graft rejection.
Smith PA; Potter TA
J Immunol; 1998 Jun; 160(11):5382-9. PubMed ID: 9605138
[TBL] [Abstract][Full Text] [Related]
17. Priming for a cytotoxic response to minor histocompatibility antigens: antigen specificity and failure to demonstrate a carrier effect.
Bevan MJ
J Immunol; 1977 Apr; 118(4):1370-4. PubMed ID: 66290
[TBL] [Abstract][Full Text] [Related]
18. T cell subsets required for in vivo and in vitro responses to single and multiple minor histocompatibility antigens.
Wettstein PJ; Korngold R
Transplantation; 1992 Aug; 54(2):296-307. PubMed ID: 1353915
[TBL] [Abstract][Full Text] [Related]
19. Immunodominant minor histocompatibility antigen peptides recognized by cytolytic T lymphocytes primed by indirect presentation.
Nevala WK; Paul C; Wettstein PJ
Transplantation; 1998 Feb; 65(4):559-69. PubMed ID: 9500633
[TBL] [Abstract][Full Text] [Related]
20. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens.
Pion S; Fontaine P; Desaulniers M; Jutras J; Filep JG; Perreault C
Eur J Immunol; 1997 Feb; 27(2):421-30. PubMed ID: 9045913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
